Skip to main content

Advertisement

Log in

Hydrochlorothiazide use is associated with the risk of cutaneous and lip squamous cell carcinoma: A systematic review and meta-analysis

  • Review
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study is to investigate the association between hydrochlorothiazide (HCTZ) use and the risk of cutaneous and lip squamous cell carcinoma development.

Methodology

We performed a systematic review and meta-analysis of case–control studies. We searched the Cochrane Library, PubMed, Scopus, Web of Science and LILACS. This study was registered in PROSPERO under protocol CRD42019129710. The meta-analysis was performed using the software Stata (version 12.0).

Results

A total of 2181 published studies referring to the theme were identified, from which six were included in this systematic review. Men were more frequently affected by cutaneous and lip squamous cell carcinoma than women, with a 1.42:1 ratio. The mean age for cutaneous and lip squamous cell carcinoma development was 73.7 years. This meta-analysis demonstrated a chance of developing cutaneous and lip squamous cell carcinoma in any region of the body in hydrochlorothiazide users of 1.76-fold higher than in non-users. In addition, a risk factor of 1.80 higher (CI 95% = 1.71–1.89) of cutaneous squamous cell carcinoma in the head and neck region was observed in HCTZ users. Moreover, in the analysis of the dose used, the chance of developing squamous cell carcinoma was 3.37-fold lower when the concentration of HCTZ used was less than 50,000 mg.

Conclusions

Our results confirm the association between the use of hydrochlorothiazide and the cutaneous and lip squamous cell carcinoma development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Liu-Smith F, Jia J, Zheng Y (2017) UV-induced molecular signaling differences in melanoma and non-melanoma skin cancer. In: Ultraviolet Light in Human Health, Diseases and Environment. Springer. p. 27–40

  2. Que SKT, Zwald FO, Schmults CD (2018) Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol 78(2):237–247

    Article  Google Scholar 

  3. Han AY, Kuan EC, Mallen-St Clair J, Alonso JE, Arshi A, St John MA (2016) Epidemiology of squamous cell carcinoma of the lip in the United States: a population-based cohort analysis. JAMA Otolaryngol Neck Surg 142(12):1216–1223

    Article  Google Scholar 

  4. Nguyen KD, Han J, Li T, Qureshi AA (2014) Invasive cutaneous squamous cell carcinoma incidence in US health care workers. Arch Dermatol Res 306(6):555–560

    Article  Google Scholar 

  5. Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE et al (2014) Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res 20(24):6582–6592

    Article  CAS  Google Scholar 

  6. Karia PS, Han J, Schmults CD (2013) Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol 68(6):957–966

    Article  Google Scholar 

  7. López EPM, Miñarro-Del Moral RM, Martínez-García C, Zanetti R, Rosso S, Serrano S et al (2003) Lifestyles, environmental and phenotypic factors associated with lip cancer: A case-control study in southern Spain. Br J Cancer 88(11):1702–1707

    Article  Google Scholar 

  8. Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA (2013) Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol 149(5):541–547

    Article  Google Scholar 

  9. Shin D, Lee ES, Kim J, Guerra L, Naik D, Prida X (2019) Association between the use of thiazide diuretics and the risk of skin cancers: A meta-analysis of observational studies. J Clin Med Res 11(4):247–255

    Article  CAS  Google Scholar 

  10. Blakely KM, Drucker AM, Rosen CF (2019) Drug-induced photosensitivity—an update: culprit drugs, prevention and management. Drug Saf 1–21

  11. Wright J, Musini V, Gill R (2018) First-line drugs for hypertension. Summary of findings for the main comparison. Cochrane Database Syst Rev (4)

  12. Gómez-Bernal S, Álvarez-Pérez A, Rodríguez-Pazos L, Gutiérrez-González E, Rodríguez-Granados MT, Toribio J (2014) Fotosensibilidad por tiazidas. Actas Dermosifiliogr 105(4):359–366

    Article  Google Scholar 

  13. Kunisada M, Masaki T, Ono R, Morinaga H, Nakano E, Yogianti F et al (2013) Hydrochlorothiazide enhances UVA-induced DNA damage. Photochem Photobiol 89(3):649–654

    Article  CAS  Google Scholar 

  14. Cognetta ABJ, Wolfe CM, Heinrichs E (2016) Hydrochlorothiazide Use and Skin Cancer: A Mohs Surgeon’s Concern. Dermatol Surg 42(9):1107–1109

    Article  CAS  Google Scholar 

  15. Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G et al (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 6(7)

  16. Fowkes FG, Fulton PM (1991) Critical appraisal of published research: introductory guidelines. BMJ Br Med J 302(6785):1136

    Article  CAS  Google Scholar 

  17. Jensen AØ, Thomsen HF, Engebjerg MC, Olesen AB, Sørensen HT, Karagas MR (2008) Use of photosensitising diuretics and risk of skin cancer: a population-based case–control study. Br J Cancer 99(9):1522

    Article  CAS  Google Scholar 

  18. Friedman GD, Asgari MM, Warton EM, Chan J, Habel LA (2012) Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med 172(16):1246–1251

    Article  Google Scholar 

  19. Pottegard A, Hallas J, Olesen M, Svendsen MT, Habel LA, Friedman GD et al (2017) Hydrochlorothiazide use is strongly associated with risk of lip cancer. J Intern Med 282(4):322–331

    Article  CAS  Google Scholar 

  20. Pedersen SA, Gaist D, Schmidt SAJ, Hölmich LR, Friis S, Pottegård A (2018) Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. J Am Acad Dermatol 78(4):673–681.e9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043483819&doi=10.1016%2Fj.jaad.2017.11.042&partnerID=40&md5=838420359eecceab374e6253d9a5a9a7. Accessed 2 Mar 2022

  21. Morales D, Pacurariu A, Slattery J, Kurz X (2020) Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: a series of population‐based nested case‐control studies. Br J Clin Pharmacol

  22. Robinson SN, Zens MS, Perry AE, Spencer SK, Duell EJ, Karagas MR (2013) Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case–control study. J Invest Dermatol 133(8):1950–1955

    Article  CAS  Google Scholar 

  23. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some Drugs and Herbal Products. Lyon (FR): International Agency for Research on Cancer (2016) (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 108.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK350406/. Accessed 2 Mar 2022

  24. Pedersen SA, Johannesdottir Schmidt SA, Holmich LR, Friis S, Pottegard A, Gaist D (2019) Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study. J Am Acad Dermatol 80(2):460-465.e9

    Article  CAS  Google Scholar 

  25. Klop WMC, Elshot YS, Beck A-JCC, Brandsen RE, Lohuis PJFM (2019) Oncodermatology of the Head and Neck. Facial Plast Surg 35(04):368–376

    Article  CAS  Google Scholar 

  26. Pereira MG, Galvão TF (2014) Heterogeneidade e viés de publicação em revisões sistemáticas. Epidemiol e Serviços Saúde 23:775–778

    Article  Google Scholar 

  27. Lomas A, Leonardi-Bee J, Bath-Hextall F (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166(5):1069–1080

    Article  CAS  Google Scholar 

  28. Gallagher RP, Lee TK, Bajdik CD, Borugian M (2010) Ultraviolet radiation. Chronic Dis Inj Can 29

  29. Rosso S, Zanetti R, Martinez C, Tormo MJ, Schraub S, Sancho-Garnier H et al (1996) The multicentre south European study’Helios’. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br J Cancer 73(11):1447

    Article  CAS  Google Scholar 

  30. Ramos J, Villa J, Ruiz A, Armstrong R, Matta J (2004) UV dose determines key characteristics of nonmelanoma skin cancer. Cancer Epidemiol Prev Biomarkers 13(12):2006–2011

    CAS  Google Scholar 

  31. Brenner M, Hearing VJ (2008) The protective role of melanin against UV damage in human skin. Photochem Photobiol 84(3):539–549

    Article  CAS  Google Scholar 

  32. Vasudev B, Hariharan S (2007) Cancer after renal transplantation. Curr Opin Nephrol Hypertens 16(6):523–528

    Article  Google Scholar 

  33. De Hertog SAE, Wensveen CAH, Bastiaens MT, Kielich CJ, Berkhout MJP, Westendorp RGJ et al (2001) Relation between smoking and skin cancer. J Clin Oncol 19(1):231–238

    Article  Google Scholar 

  34. Marehbian J, Colt JS, Baris D, Stewart P, Stukel TA, Spencer SK et al (2007) Occupation and keratinocyte cancer risk: a population-based case–control study. Cancer Causes Control 18(8):895–908

    Article  Google Scholar 

  35. Leonardi-Bee J, Ellison T, Bath-Hextall F (2012) Smoking and the risk of nonmelanoma skin cancer: systematic review and meta-analysis. Arch Dermatol 148(8):939–946

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank the National Council for Scientific and Technological Development (CNPq, Brazil), and the Coordination for the Improvement of Higher Education Personnel (CAPES, Brazil).

Author information

Authors and Affiliations

Authors

Contributions

Andrade, Felix and França had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Andrade, Felix and França. Acquisition, analysis, or interpretation of data: All authors. Drafting of the manuscript: All authors. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Ribeiro and Andrade. Obtained funding: no one. Supervision, and administrative, technical, or material support: Costa, Castro and Barboza.

Corresponding author

Correspondence to Ana Cláudia de Macedo Andrade.

Ethics declarations

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent to publish

Not applicable.

Statement of prior presentation

The work here has not been previously published

Conflict of interest disclosures

The authors declare no conflict of interest during the time involving the work, from initial conception and planning to present.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 444 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Macedo Andrade, A.C., Felix, F.A., França, G.M. et al. Hydrochlorothiazide use is associated with the risk of cutaneous and lip squamous cell carcinoma: A systematic review and meta-analysis. Eur J Clin Pharmacol 78, 919–930 (2022). https://doi.org/10.1007/s00228-022-03299-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-022-03299-x

Keywords

Navigation